Abstract:A dysregulated immune response toward self-antigens characterizes autoimmune and autoinflammatory (AIF) disorders. Autoantibodies or autoreactive T cells contribute to autoimmune diseases, while autoinflammation results from a hyper-functional innate immune system. Aside from their differences, many studies suggest that monocytes and macrophages (Mo/Ma) significantly contribute to the development of both types of disease. Mo/Ma are innate immune cells that promote an immune-modulatory, pro-inflammatory, or repair response depending on the microenvironment. However, understanding the contribution of these cells to different immune disorders has been difficult due to their high functional and phenotypic plasticity. Several factors can influence the function of Mo/Ma under the landscape of autoimmune/autoinflammatory diseases, such as genetic predisposition, epigenetic changes, or infections. For instance, some vaccines and microorganisms can induce epigenetic changes in Mo/Ma, modifying their functional responses. This phenomenon is known as trained immunity. Trained immunity can be mediated by Mo/Ma and NK cells independently of T and B cell function. It is defined as the altered innate immune response to the same or different microorganisms during a second encounter. The improvement in cell function is related to epigenetic and metabolic changes that modify gene expression. Although the benefits of immune training have been highlighted in a vaccination context, the effects of this type of immune response on autoimmunity and chronic inflammation still remain controversial. Induction of trained immunity reprograms cellular metabolism in hematopoietic stem cells (HSCs), transmitting a memory-like phenotype to the cells. Thus, trained Mo/Ma derived from HSCs typically present a metabolic shift toward glycolysis, which leads to the modification of the chromatin architecture. During trained immunity, the epigenetic changes facilitate the specific gene expression after secondary challenge with other stimuli. Consequently, the enhanced pro-inflammatory response could contribute to developing or maintaining autoimmune/autoinflammatory diseases. However, the prediction of the outcome is not simple, and other studies propose that trained immunity can induce a beneficial response both in AIF and autoimmune conditions by inducing anti-inflammatory responses. This article describes the metabolic and epigenetic mechanisms involved in trained immunity that affect Mo/Ma, contraposing the controversial evidence on how it may impact autoimmune/autoinflammation conditions.

Metabolic Regulation in the Induction of Trained Immunity

The Role of Cell Metabolism in Innate Immune Memory

Innate Immune Memory Of Tissue-Resident Macrophages And Trained Innate Immunity: Re-Vamping Vaccine Concept And Strategies

Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and is Critical to Trained Immunity

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter

Trained immunity: adaptation within innate immune mechanisms.

Trained immunity: General and emerging concepts

The lncRNA Connection Between Cellular Metabolism and Epigenetics in Trained Immunity

The causes and consequences of trained immunity in myeloid cells

Trained innate immunity: concept, nomenclature and future perspectives

Trained Immunity Contribution to Autoimmune and Inflammatory Disorders

Defining trained immunity and its role in health and disease

Metabolic programs of T cell tissue residency empower tumour immunity

The mechanisms and cross-protection of trained innate immunity

Innate Immune Memory and the Host Response to Infection

Trained immunity is regulated by T cell-induced CD40-TRAF6 signaling

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses

Epigenetic Regulation of Innate Immune Memory in Microglia

Metabolic Flexibility Assists Reprograming of Central and Peripheral Innate Immunity During Neurodevelopment

Divergent metabolic programmes control two populations of MAIT cells that protect the lung

Therapeutic targeting of trained immunity